Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Societe Generale Downgrades Alcon to Sell

Societe Generale analyst Delphine Le Louet downgrades Alcon (NYSE:ALC) from Hold to Sell.

byBenzinga Newsdesk

November 17, 2022

1 minute read

Societe Generale analyst Delphine Le Louet downgrades Alcon (NYSE:ALC) from Hold to Sell.

MINISO Group Holding Q4 EPS $0.07, Sales $382.90M

By Benzinga Newsdesk

Today, 8:46 PM

MINISO Group Holding (NYSE:MNSO) reported quarterly earnings of $0.07 per share. The company reported $382.90 million in sales this quarter.

MNSO

Goldman Sachs Maintains Buy on ON Semiconductor, Raises Price Target to $70

By Benzinga Newsdesk

Today, 8:46 PM

Goldman Sachs maintains ON Semiconductor (NASDAQ:ON) with a Buy and raises the price target from $62 to $70.

UBS Maintains Buy on Bombardier, Lowers Price Target to $2.4

By Vick Meyer

Today, 8:46 PM

UBS maintains Bombardier (TSX:BBD) with a Buy and lowers the price target from $3.2 to $2.4.

TSX:BBD

Seagen’s Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer

By Vandana Singh

Today, 8:46 PM

The FDA has granted accelerated approval to Seagen Inc’s (NASDAQ:SGEN) Tukysa (tucatinib) in combination with trastuzumab for colorectal cancer. The approval covers…

MRK

Societe Generale Downgrades Alcon to Sell

Related Posts

MINISO Group Holding Q4 EPS $0.07, Sales $382.90M

Goldman Sachs Maintains Buy on ON Semiconductor, Raises Price Target to $70

UBS Maintains Buy on Bombardier, Lowers Price Target to $2.4

Seagen’s Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer